Ifosfamide 2gm Injection Celofos

The effects of ifosfamide 1500 mg/m2/day IV on days 1—5 and mesna 750 mg/m2/day IV every 4 hours for three doses (beginning just before Celofos 2gm Injection) on days 1—5, every three weeks, were investigated. In conjunction with gemcitabine, for the treatment of recurrent metastatic bladder cancer. The dosage is unknown.

Celofos is a drug that is used in combination with other drugs to treat testicular cancer that has not improved or worsened after treatment with other drugs or radiation therapy. Injection belongs to the alkylating agent class of drugs.

Celofos 2gm Injectionis a cytotoxic, anticancer medicine that is used to control and treat diseases such lymphoma, sarcoma, and lung cancer.

IFEX should be given as a gradual intravenous infusion that lasts at least 30 minutes. Other references 2: Diluted for administration solutions are stable for 7 days at room temperature and 6 weeks when refrigerated. Reconstituted solutions can be kept for up to 21 days in the refrigerator.

5-FU (flure oh YOOR a sil) is a chemotherapeutic medication. It inhibits cancer cell growth. Breast cancer, colon or rectal cancer, pancreatic cancer, and stomach cancer are all treated with this medication.

Background: The two most active medicines in the treatment of adult soft tissue sarcoma are doxorubicin and Celofos 2gm Injection (STS). When coupled with ifosfamide, etoposide has significant activity against a wide range of cancers, and it is especially effective against sarcomas in adolescents and young adults.

• Typical side effects

• An infection is more likely to occur.

• Breathlessness and a pallid appearance

• Bruising, gum bleeding, or nosebleeds.

• Fatigue and exhaustion (fatigue) during and after therapy.

• Being sick or feeling unwell.

• a loss of appetite

• Hair thinning…

• The bladder and kidneys are irritated.

Read more

You can explore more Anti Cancer products by clicking here 

We are an exporter from India and work in excess countries like the UAE, Oman, Qatar, Myanmar, Saudi Arabia, Netherlands, Albania, Saint Lucia, Jordan, Romania, South Africa, and so on.